Study finds long-term cognitive and psychiatric issues persist in COVID-19 patients two to three years post-infection

A recent study investigated whether psychiatric and cognitive symptoms commence or persist beyond a year of COVID-19-related hospitalization.

Endocrine Society’s Journal of the Endocrine Society receives first Impact Factor score

The Endocrine Society’s Journal of the Endocrine Society (JES) received its first Impact Factor score in 2022, while the Society’s other journals maintained high rankings

July 3, 2023

FTC issues warnings on ‘junk’ patent listings for Ozempic and other drugs

The U.S. Federal Trade Commission expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings pertaining to 20 different brand-name treatments

April 30, 2024

Neurocrine Biosciences drug for congenital adrenal hyperplasia succeeds in late-stage trial

SAN DIEGO — Neurocrine Biosciences announced on Tuesday that an experimental drug for congenital adrenal hyperplasia succeeded in a late-stage trial, bringing the company a

September 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.